about
Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation.Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials.A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation.Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma.A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation.Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases.Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients.HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin).Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation.Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma.Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation.Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation.Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation.Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients.Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning.Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin.Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success.Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation.Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation.Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors.Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL.Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantationAdditional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor EraFalse-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantationA combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemiaAssociation between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow TransplantationOutcome of gastrointestinal graft-versus-host disease according to the treatment response
P50
Q33432975-1AEF674F-DCA5-479C-A580-541283998710Q33441641-ECB136D0-1ECA-4DEB-867D-32459413D994Q35105169-F03C866D-7DE6-45CC-A263-42CB302A394CQ38584425-85B3C2EA-67C3-4975-93D3-F4450363EFD6Q39385600-321BB6B9-14FE-4A1E-8ED1-94897BFA7967Q40102725-DAC0C3B3-B4CD-4DB6-88C4-6202653DA705Q40116023-8F7240C2-6FE5-4C97-9FC5-952C8E2BB974Q40137330-6948AA66-4574-470C-8359-9DCA349F1DA3Q40174281-6BA20E3B-A329-41B4-B218-551EB3E2B39FQ40307013-3788C541-7178-4815-9B30-80A6048903B9Q40342256-6288D2D7-03E1-4C52-9DF4-47815B318F94Q40384599-FBD657A7-1329-4710-AFFE-267B0D1E3B07Q40397260-9845A58D-DC88-4D0C-9BAC-DB69500003F1Q40428384-F7B89E4A-6C57-4671-8735-10E9CC13068FQ40739141-58005438-237E-46C0-8143-5CA21BA986F7Q40922474-6208E466-FF43-4D79-AEFE-66AF2E2D8B16Q41008753-05ADA22F-BE58-4DE0-8594-CBBE0E0DFF80Q41489633-1C7A737F-44F5-45FC-AF54-F3137F29C16AQ41549771-2BCC8A3F-7E9A-4256-8FCE-6B93AA4BF921Q42180502-6F0B2677-DBB3-48F7-BBAE-C46347F69560Q42182292-D574CC58-CAE5-44E3-954F-A37FC994B60FQ42208353-27FA37D5-A48B-4216-88BD-8B89E04A3021Q42233134-258582AC-40F3-4728-916A-357E4A27F50BQ42245323-2C400A79-3E0C-4E7E-98BD-0FF33FFD9436Q44380574-A181B2FD-F04C-434B-9586-E1C876AC625EQ46181753-8C7E7ED1-8C25-4A7E-96E5-C4F98342436EQ50908224-BDD25BA2-D5FD-48A4-9FB4-7E7C47B8219EQ51780256-07599193-41B2-4CC3-9847-CC30E07F4CFCQ52687295-1C56C1BD-4137-405D-B41B-E547AA955FFDQ52746966-99677B59-194C-4D72-AB77-674E70AC1F31Q52747009-9423E540-09FC-4DF0-9BED-C577785542DDQ52763314-FA1B205D-365A-48BC-B5A6-E973A965C6ECQ52763377-13835364-F698-48E9-A44E-CA48DF75DE44Q52915505-30DA1082-5889-48B1-9139-557D1D702352Q58593465-4FFC8ECE-BC06-40D2-8BCF-EAFA72136B79Q64124173-9D0436B7-7E3C-48F0-BF70-9FF01F70C321Q86874704-2B594AA6-28A6-4178-82AB-59489382A286Q87217887-0D7A0C30-93B8-4EEA-9735-B860B829DA9DQ88003921-A6063C3B-1874-4986-94BD-809840CF0778Q88961816-6AEA85B6-85A7-44A1-A46C-8B32527CCABA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yu Akahoshi
@ast
Yu Akahoshi
@en
Yu Akahoshi
@es
Yu Akahoshi
@sl
type
label
Yu Akahoshi
@ast
Yu Akahoshi
@en
Yu Akahoshi
@es
Yu Akahoshi
@sl
prefLabel
Yu Akahoshi
@ast
Yu Akahoshi
@en
Yu Akahoshi
@es
Yu Akahoshi
@sl
P106
P31
P496
0000-0001-6825-9340